A glance on severe acute respiratory syndrome coronavirus 2 (SARS COV-2): A brief review

Muthanna Medical Journal

Volume 9, Issue 2,  2022 Page 105-110

Marwa Mohammed Ali Jassim¹ , Abeer Mohammed Ali Al-Garawyi², Murtada Hafedh Hussein ³ 

Correspondence author: marwa.mohammed@mu.edu.iq

¹ College of Dentistry, Al-Muthanna University

² College of Medicine, Al-Muthanna University
³ College of science, Thi-Qar university, Thi-Qar
Received 27 July 2022, Accepted 05 September 2022, Available online 27 September 2022.
Copyright © 2022 MA. This is article distributed under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


“coronavirus disease 2019” is a highly contagious and infectious illness and cause globally acute upper respiratory systemic disease at latest 2019, major causing agent is “coronavirus-2” descent; also called “SARS  COV-2”. A “coronavirus” have a lower mortality in parallel with others, (SA.RS..-CoV and ME.RS-CoV). In majority of people illness is in medium state; nevertheless, pneumonia may be develop, acute distress syndrome (AR.DS), and dysfunction in multiple organs (typically the aged and who having several other illness). many people are asymptomatic, while around 20% have moderate-to-severe illness. In current topic, can summarize the virologic basic of “coronavirus”, which includes clinical features, ligand usage, mutations, epidemiology, pathogenesis, and highlighting its significant differences from previously known coronaviruses.

Keywords: COVID-19, SARS-CoV-2, ARDS, MERS-CoV, Pneumonia